Z-2037-2023 Class II Ongoing
FDA device recall Z-2037-2023 was initiated by Implant Direct Sybron Manufacturing LLC on May 2, 2023 and is designated Class II. Reason for recall: Non-engaging abutments were distributed without FDA clearance; the performance characteristics have not yet been adequately established. The recall status is ongoing. Affected quantity: 29.
Recall details
- Product Type
- Devices
- Report Date
- Jul 5, 2023
- Initiation Date
- May 2, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29
Product description
LEGACY SMARTBASE, NE 3.0D 1MML, REF: 8730-81NE; LEGACY SMARTBASE, NE 3.0D 2MML, REF 8730-82NE; LEGACY SMARTBASE NARROW NE 3.5D, REF: 8735-80NNE; LEGACY SMARTBASE, NE 3.5D 2MML, REF: 8735-82NE LEGACY SMARTBASE NARROW NE 4.5D, REF: 8745-80NNE; LEGACY SMARTBASE. NE 4.5D, REF: 8745-82NE;
Reason for recall
Non-engaging abutments were distributed without FDA clearance; the performance characteristics have not yet been adequately established.
Distribution pattern
US Nationwide distribution in the states of FL, ID, TX, CA.
Code information
REF/UDI-DI/Lot: 8730-81NE/10841307123002/92637, 131309; 8730-82NE/10841307123019/92638, 163063; 8735-80NNE/10841307123026/160542; 8735-82NE/10841307123064/15002360; 8745-80NNE/10841307123033/15004780; 8745-82NE/10841307123071/182029;
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2037-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026